A PAPER published in the Annals
of Family Medicine examining
data from a large cohort of
patients supports other recent
conclusions that treatment with
the antithrombotic azithromycin
(Zithromax/Zmax) significantly
increases the risk of death and
cardiac arrhythmia in the first five
days of treatment.
Another link was drawn between
antibiotic levofloxacin (Levaquin)
and a similar increased risk.The above article was sent to subscribers in Pharmacy Daily's issue from 12 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Mar 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.